shoutout to the PR co too -- brilliant tactic to release this, with its specific, substantive assertions about the improved relationship with the FDA, study moving forward with a distinguished CRO, ON THE DAY that the court case is supposed to produce some kind of news..any short BS can easily be countered with this PR, as in "that was then, this is now".